Name | Betifisolimab |
---|
Description | Betifisolimab (MSB-2311) is a humanized monoclonal antibody directed against the immunosuppressive ligand PD-L1. Betifisolimab has the potential for advanced solid tumors and hematological malignancies research[1]. |
---|---|
Related Catalog | |
In Vitro | Betifisolimab (MSB-2311) 是一种人源化 PD-L1 抗体,具有独特的 pH 依赖性抗原结合特性,可实现肿瘤内循环并增强肿瘤渗透[1]。 |
References |
No Any Chemical & Physical Properties |